Epsilon M&A Deal Report - Chronolyss (Dinno Santé)

Transaction Multiples for the Valuation of Private Companies

Private Group led by Argos Soditic > Chronolyss (Dinno Santé)

Announced Date : 28 May 2007

Type : MBI (Management Buy In)

Deal Value : Yes

Acquirer : Private Group led by Argos Soditic

Target: Chronolyss (Dinno Santé)

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1992, Chronolyss (renamed Dinno ...

No EMAT : 19585

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
31/08/2008 Holding Sanita e Servizi Centro Cardinal Ferrari Italy 0
04/08/2008 Charles River Laboratories International NewLab BioQuality Germany 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database